Baldwin Wealth Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-47
| Closed | -$75 | – | 803 |
|
|
2023
Q1 | $75 | Hold |
47
| – | – | ﹤0.01% | 798 |
|
|
2022
Q4 | $69 | Hold |
47
| – | – | ﹤0.01% | 779 |
|
|
2022
Q3 | $0 | Hold |
47
| – | – | ﹤0.01% | 711 |
|
|
2022
Q2 | $0 | Hold |
47
| – | – | ﹤0.01% | 712 |
|
|
2022
Q1 | $0 | Hold |
47
| – | – | ﹤0.01% | 705 |
|
|
2021
Q4 | $0 | Hold |
47
| – | – | ﹤0.01% | 661 |
|
|
2021
Q3 | $0 | Hold |
47
| – | – | ﹤0.01% | 678 |
|
|
2021
Q2 | $1K | Hold |
47
| – | – | ﹤0.01% | 655 |
|
|
2021
Q1 | $0 | Hold |
47
| – | – | ﹤0.01% | 639 |
|
|
2020
Q4 | $0 | Hold |
47
| – | – | ﹤0.01% | 569 |
|
|
2020
Q3 | $0 | Sell |
47
-1
| -2% | – | ﹤0.01% | 553 |
|
|
2020
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 560 |
|
|
2020
Q1 | $1K | Hold |
48
| – | – | ﹤0.01% | 540 |
|
|
2019
Q4 | $1K | Hold |
48
| – | – | ﹤0.01% | 534 |
|
|
2019
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 515 |
|
|
2019
Q2 | $1K | Hold |
48
| – | – | ﹤0.01% | 504 |
|
|
2019
Q1 | $2K | Hold |
48
| – | – | ﹤0.01% | 495 |
|
|
2018
Q4 | $1K | Hold |
48
| – | – | ﹤0.01% | 496 |
|
|
2018
Q3 | $3K | Hold |
48
| – | – | ﹤0.01% | 500 |
|
|
2018
Q2 | $4K | Hold |
48
| – | – | ﹤0.01% | 486 |
|
|
2018
Q1 | $5K | Buy |
+48
| New | +$5K | ﹤0.01% | 453 |
|